Jan M. Lundberg

Leeftijd : 67

Vermogen : 382 011 USD

Belangrijkste bedrijven :

Overzicht

Jan M. Lundberg founded Aerocrine AB. Dr. Lundberg is on the board of Metabolon, Inc. and 7 other companies.

In his past career he occupied the position of Executive Vice President-Science & Technology at Eli Lilly & Co. and President of Lilly Research Laboratories (a subsidiary of Eli Lilly & Co.), Executive Vice President-Discovery Research at AstraZeneca Plc Executive Vice President-Global Discovery Research at AstraZeneca AB and Head-Preclinical Research at Astra AB (both are subsidiaries of AstraZeneca Plc) and Professor at Karolinska Institutet.

Dr. Lundberg received a doctorate from Karolinska Institutet and a doctorate from the University of Gothenburg.

Posities en verantwoordelijkheden van Jan M. Lundberg

Naam	Titel	Van
Ardelyx, Inc. (Biotechnologie & Medisch Onderzoek)	Independent Director	2018
Metabolon, Inc.	Director	2019
Biotechnology Innovation Organization	Director	-
PhRMA Foundation	Director	-
Betagenon Sweden AB	Director	2019
Transcelerate Biopharma, Inc.	Director	-
Anocca AB	Director	-
Balticgruppen Bio AB	Director	-

Belangnemingen van Jan M. Lundberg

Naam	Aandelen	%	Totale waarde
Ardelyx, Inc. (ARDX) (Biotechnologie & Medisch Onderzoek)	134 039	0,072%	382 011 USD

Jan M. LundbergPersoonlijk netwerk

Naam	Verwante bedrijven
David M. Mott	Ardelyx, Inc. Biotechnology Innovation Organization
Michael G. Raab	Ardelyx, Inc. Biotechnology Innovation Organization
Svein Arild Mathisen	Balticgruppen Bio AB Betagenon Sweden AB
Steven C. Gilman	PhRMA Foundation Transcelerate Biopharma, Inc.
Justin A. Renz	Ardelyx, Inc.
William C. Bertrand	Ardelyx, Inc.
Robert B. Bazemore	Ardelyx, Inc.
Robert Felsch	Ardelyx, Inc.
Onaiza Cadoret-Manier	Ardelyx, Inc.
Richard J. Rodgers	Ardelyx, Inc.